Catalys Pacific, LLC

TOKYO, null · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 30, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$209.7M2026 Q3
Positions2
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Catalys Pacific, LLC reported 2 positions worth $209.7M as of September 30, 2026 (13F filed October 30, 2026). Largest holding: MLYS (93.5%). Biggest move: add PHAT ($2.8M).

2 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 MLYSMineralys Therapeutics$196.0M93.45%7,799,518——-39.0%
▸ 2 PHATPhathom Pharmaceuticals$13.7M6.55%1,882,039——-17.0%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Catalys Pacific, LLC hold as of Q3 2026?

Catalys Pacific, LLC reported 2 positions worth $209.7M in its Q3 2026 13F filing. Largest positions: MLYS (93.5%) and PHAT (6.5%).

What did Catalys Pacific, LLC buy in Q3 2026?

Added to: PHAT.

What did Catalys Pacific, LLC sell in Q3 2026?

Reduced: MLYS.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.